Vanda Pharmaceuticals (VM4.F) Q4 2024 Earnings

Nov 6Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.18
-0.1
-0.03
0.05

Details

Expected EPS
-0.14377800591
Actual EPS
-0.0825957
Surprise EPS
0.06
Surprise Percent
+42.55%

Description

⁨Vanda Pharmaceuticals⁩ (⁦VM4.F⁩) has reported earnings of ⁦-0.0825957⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts